Jupiter Life Line Hospitals Ltd (JLHL) Q2FY27 Concall Transcript - Sep-2026 Qtr
Moderator: Your passcode has been confirmed. Please wait while you are joined to the conference. The conference is now being recorded.
Moderator: Ladies and gentlemen, you are connected for Jupiter Life Line Hospitals Limited Q2 and H1 FY '27 earnings conference call. Please stay connected, the conference will begin shortly.
Moderator: Ladies and gentlemen, good day and welcome to Jupiter Life Line Hospitals Limited Q2 and H1 FY '27 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. As a reminder, all participants' lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing "*" then "0" on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Dr. Ankit Thakker, Managing Director and CEO. Thank you and over to you, sir.
Ankit Thakker (Jupiter Life Line Hospitals Ltd): Good morning, everyone. I thank you for joining us on our earnings call to discuss the business and financial performance of Q2 and H1 FY '27. I hope everyone had a chance to view our financial results and investor presentation, which were posted on our website and the stock exchanges. I am joined this morning by Mr. Anand Apte, our Chief of Business and Strategy; Mr. Aditya Gupta, our Senior VP, Corporate Affairs; Mr. Nitin Patodia, Head of Finance; Suma Uppalapati, our Company Secretary and Compliance Officer; and our investor relations advisors on the call from SGA. I'm pleased to share with all of you that following successful negotiations with the landowner
Ankit Thakker (Jupiter Life Line Hospitals Ltd): Board has approved the acquisition of the land currently leased for our Pune South hospital. The land measures 11,452 sq m, and the total agreed consideration for the land is 150 crores. The 50 crores of deposit that was already paid earlier will be adjusted against this. So, the incremental cash outflow for the company is limited to 100 crores. The land is expected to be registered in our name in the coming few days. We've always said that we prefer to own the land on which our hospitals are built, as it gives us control, certainty, and better long-term financial value. The Pune South project is also progressing well and remains on schedule. At Mira Bhayandar, the project is currently in the regulatory stage and we expect to commence the next phase of activities before the end of this financial year. BKC is in the planning stage and will soon go into the regulatory clearance process. Coming to our operating hospitals, our existing hospitals continue to perform in line with expectations with Thane, Pune, and Indore, all staying on course. At Dombivli, the ramp-up is continuing well. The EBITDA impact on the hospitals was 20 lakhs in Q2 compared to 9.5 crores in Q1. Part of this improvement reflects higher medical admissions during the quarter, driven by a seasonally higher infectious disease burden in this region. This has traditionally been the case with all of our existing hospitals as well, where Q2 occupancy has been higher than Q1 and Q3. The overall ramp-up trajectory of Dombivli, however, remains intact. Moving to the financial performance, Q2 numbers, the income stood at 456.5 crores in this quarter. The EBITDA stood at 106.9 crores in this quarter with a PAT of 56.4 crores. Half-yearly numbers, the income is 867.5 crores with EBITDA of 186.2 crores and a PAT of 93.9 crores. The ARPOB is 71,800. The IP ARPOB is 58,700. The ALOS is 3.79 days. And the occupancy for first half is 59.5 for all the hospitals. But excluding Dombivli, the occupancy is 64.8%. So, with this, I'm happy to take your questions. Thank you.
Moderator: Thank you very much. We will now begin with a question and answer session. Anyone who wishes to ask a question may press star and one on the touchtone phone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we'll wait for a moment while the question queue assembles. The first question is from the line of Albin Benny from JM Financial. Please go ahead.
Albin Benny (JM Financial): Thank you. Hope I'm audible. First of all, congratulations to the management for the great set of numbers. So, my first question, if you could indicatively help us understand what kind of revenues did Dombivli clocked in the quarter and the kind of occupancy levels we executed for the hospital?
Ankit Thakker (Jupiter Life Line Hospitals Ltd): So, currently we have not been giving unit wise revenue numbers. So, I would not have that accessible with me.
Albin Benny (JM Financial): Sure, sir. But in terms of metrics, what kind of occupancy levels that we are seeing right now and given this higher infectious diseases that are there, what kind of metrics or the the evolution are we seeing right now?
Ankit Thakker (Jupiter Life Line Hospitals Ltd): So, currently occupancy should be in mid-30s.
Albin Benny (JM Financial): 30%, right? For sure, sir. Thank you. And my second question regarding the mature assets, especially Pune and Thane that is there, any brownfield bed expansion opportunities that we might have here? Any kind of bed increases that can we can see? And second, growth here indicatively, as you have earlier also mentioned, that is much linked to inflation. Apart from that, occupancy wise, any levers that we can probably see in future?
Ankit Thakker (Jupiter Life Line Hospitals Ltd): So, Pune, there is no further scope of expansion.
101 more turns of this transcript: log in to Stocksigma to read the full call.